Abstract
This listing includes new single chemical entities and preparations, duplicate single products, and combination products that have been made available for clinical use by the U.S. Food and Drug Administration during the period January 21 to March 20, 1972. This information is taken from the manufacturer's package insert or brochure, which should be consulted for further details on indications, dosage, contraindications, and adverse reactions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Clinical Pharmacology and New Drugs
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
